We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Officials at Rentschler Biopharma emphasize that biologics (cell culture-based therapeutic proteins) remain central to its operations.

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

United Parcel Service, Inc. (NYSE:UPS), the world's largest package delivery company, continues to navigate a complex and ...

The global market for Biological Drugs was estimated at US$345.3 Billion in 2023 and is projected to reach US$634.4 Billion by 2030, growing at a CAGR of 9.1% from 2023 to 2030. This comprehensive ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...

The pharmaceutical packaging equipment market is growing rapidly, driven by increasing demand for automation, regulatory compliance, and the rise of biologics and personalized medicines. Advanced ...

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion ...

While most of its current revenue comes from the contract manufacturing business, Samsung Biologics aims to increase its exposure in the contract development organization business, which provides a ...

A diverse group of Baltimore startups poised for growth this year includes companies focused on climate prediction technology ...